Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
Page 2

The organizers of the program reckon that through the leveraging of the strengths, the pace of grant-funded medications development for SUDs will be substantially accelerated. As a result, the organizers encourage the proposals to be submitted under this program to focus at any point along the drug development continuum.

The initiative is also inspired by the fact that there is presently no FDA-approved medications for the treatment of cocaine, methamphetamine, or cannabis use disorders. To this regard, the NIH and NIDA hope that the results of the program will accelerate medication development, foster collaborative ventures between entities such that each offers financial resources, in-kind resources, and/or expertise toward the development of safe and effective medications for SUDs.

To support this program, the NIH and NIDA are willing to administer funds in the amount of $2,000,000 per year for a project that could last for up to 3 years.

The institutions and organizations who will be deemed eligible to take part in the program are the following:

a) Higher Education Institutions such as Public and Private Institutions of Higher Education

b) Nonprofit Organizations

c) For-profit Organizations Such as Small Businesses

d) State Governments, County Governments, City or Township Governments, Special District Governments, and Indian/Native American Tribal Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations, and Faith-based or Community-based Organizations

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on children grants and education grant money.

Additional Resources

category - Health Grants

National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults
The National Institutes of Health has recently established a program entitled Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults wherein they intend to kick-off research studies that will create, implement, and evaluate both old and new interventions that are geared towards improving adherence to medical and behavioral regimens for HIV-positive adolescents which are 11 to 21 years old and adults who are 21 to 24 years old.

---

Department of Agriculture: Value Added Producer Grants
The Value-Added Producer Grants program is geared towards helping the Independent Producers of Agricultural Commodities, Agriculture Producer Groups, Farmer and Rancher Cooperatives, and Majority-Controlled Producer-Based Business Ventures in developing techniques that would create marketing opportunities and establish business plans involving viable marketing opportunities that involve the production of bio-based products from agricultural commodities.

---

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care Program
The National Institutes of Health has recently established the Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care Program wherein it intends to utilize common conceptual models in creating independent interventions that will contribute to the modification of health behaviors and the improvement of health outcomes in patients diagnosed with co-morbid chronic diseases and health conditions.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---